Empagliflozin
Vascular Health
VA Office of Research and DevelopmentSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
3 Active assets in the Vascular Health cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Triticum Aestivum Coordinación de Investigación en Salud, Mexico | Phase 3 | BB |
Calcined Magnesia Coordinación de Investigación en Salud, Mexico | Phase 3 | BB |
Kln-1010 Kelonia Therapeutics, Inc. | Phase 1 | CC |
Same molecule, other indications
Empagliflozin is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →